Compare ATRA & CGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATRA | CGO |
|---|---|---|
| Founded | 2012 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 99.1M | 114.5M |
| IPO Year | 2014 | N/A |
| Metric | ATRA | CGO |
|---|---|---|
| Price | $15.69 | $11.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $21.00 | N/A |
| AVG Volume (30 Days) | ★ 63.1K | 34.7K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.25% |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.97 | N/A |
| Revenue | ★ $151,930,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $7.98 | ★ N/A |
| Revenue Growth | ★ 51.27 | N/A |
| 52 Week Low | $5.01 | $7.90 |
| 52 Week High | $18.71 | $10.93 |
| Indicator | ATRA | CGO |
|---|---|---|
| Relative Strength Index (RSI) | 60.46 | 48.66 |
| Support Level | $12.05 | $11.21 |
| Resistance Level | $15.12 | $11.50 |
| Average True Range (ATR) | 1.08 | 0.15 |
| MACD | 0.20 | 0.05 |
| Stochastic Oscillator | 93.44 | 85.71 |
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
Calamos Global Total Return Fund is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The fund invests in equities, convertible securities, and high-yield corporate bonds.